E-LIB Suche - Ergebnisse für: Takeyasu, Yuki

1

Distinct Progression and Efficacy of First-Line Osimertinib..:

Takeyasu, Yuki ; Yoshida, Tatsuya ; Masuda, Ken...
JTO Clinical and Research Reports. 5 (2024) 2 - p. 100636 , 2024

2

Investigation of a practical assessment index to capture th..:

Katsushima, Utae ; Hase, Kimitaka ; Fukushima, Takuya...
Japanese Journal of Clinical Oncology. 54 (2024) 3 - p. 305-311 , 2024

Link: https://doi.org/10.1093/..

3

Impact of ramucirumab pharmacokinetics in combination with ..:

Akagi, Kazumasa ; Yagishita, Shigehiro ; Ohuchi, Mayu...
Lung Cancer. 178 (2023) - p. 247-253 , 2023

Link: https://doi.org/10.1016/..

4

Disease progression status during initial immune checkpoint..:

Torasawa, Masahiro ; Yoshida, Tatsuya ; Takeyasu, Yuki...
Cancer Medicine. 12 (2023) 11 - p. 12388-12401 , 2023

Link: https://doi.org/10.1002/..

5

Prognostic role of modified Glasgow Prognostic score in eld..:

Tanaka, Tomohiro ; Yoshida, Tatsuya ; Masuda, Ken...
Respiratory Investigation. 61 (2023) 1 - p. 74-81 , 2023

Link: https://doi.org/10.1016/..

6

End‐of‐life impact of concurrent diabetes mellitus and adre..:

Nakamura, Tomoaki ; Takeyasu, Yuki ; Yoshida, Tatsuya..
Thoracic Cancer. 13 (2022) 21 - p. 3073-3075 , 2022

Link: https://doi.org/10.1111/..

7

Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients..:

Takeyasu, Yuki ; Yoshida, Tatsuya ; Masuda, Ken...
JTO Clinical and Research Reports. 3 (2022) 5 - p. 100311 , 2022

Link: https://doi.org/10.1016/..

8

Feasibility of next-generation sequencing (Oncomine™ DX Tar..:

Takeyasu, Yuki ; Yoshida, Tatsuya ; Motoi, Noriko...
Japanese Journal of Clinical Oncology. 51 (2021) 7 - p. 1114-1122 , 2021

Link: https://doi.org/10.1093/..

9

Differential Efficacy of Pembrolizumab According to Metasta..:

Takeyasu, Yuki ; Yoshida, Tatsuya ; Shibaki, Ryota...
Clinical Lung Cancer. 22 (2021) 2 - p. 127-133.e3 , 2021

Link: https://doi.org/10.1016/..

10

Corrigendum to: Feasibility of next-generation sequencing (..:

Takeyasu, Yuki ; Yoshida, Tatsuya ; Motoi, Noriko...
Japanese Journal of Clinical Oncology. 51 (2021) 7 - p. 1183-1183 , 2021

Link: https://doi.org/10.1093/..

11

The Impact of Core Tissues on Successful Next-Generation Se..:

Uchimura, Keigo ; Yanase, Komei ; Imabayashi, Tatsuya...
Cancers. 13 (2021) 23 - p. 5879 , 2021

Link: https://doi.org/10.3390/..

12

Prognostic role of immunosenscence associated with index in..:

Tanaka, Tomohiro ; Yoshida, Tatsuya ; Masuda, Ken...
Journal of Global Oncology. 5 (2019) suppl - p. 100-100 , 2019

Link: https://doi.org/10.1200/..

13

Neutrophil-to-lymphocyte ratio as an early marker of outcom..:

Nakaya, Aya ; Kurata, Takayasu ; Yoshioka, Hiroshige...
International Journal of Clinical Oncology. 23 (2018) 4 - p. 634-640 , 2018

Link: https://doi.org/10.1007/..

14

Comparative study of programmed cell death ligand-1 immunoh..:

Saito, Tomohito ; Tsuta, Koji ; Ishida, Mitsuaki...
Lung Cancer. 125 (2018) - p. 230-237 , 2018

Link: https://doi.org/10.1016/..

15

Interstitial Lung Disease Following Single-Agent Nanopartic..:

Nakatani, Yuki ; Nakaya, Aya ; Kurata, Takayasu...
Case Reports in Oncology. 10 (2017) 2 - p. 683-688 , 2017

Link: https://doi.org/10.1159/..